PET beyond Deauville in diffuse large B-cell lymphoma by Rutherford, Sarah C

Get full text

Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA by Rutherford, Sarah C., Herold, Michael, Hiddemann, Wolfgang, Kostakoglu, Lale, Marcus, Robert, Martelli, Maurizio, Sehn, Laurie H., Trněný, Marek, Trotman, Judith, Vitolo, Umberto, Nielsen, Tina, Mattiello, Federico, Sahin, Deniz, Sellam, Gila, Martin, Peter

Get full text

Surveillance scanning in lymphoma by Rutherford, Sarah C

Get full text

Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL by Ruan, Jia, Moskowitz, Alison, Mehta-Shah, Neha, Sokol, Lubomir, Chen, Zhengming, Kotlov, Nikita, Nos, Grigorii, Sorokina, Maria, Maksimov, Vladislav, Sboner, Andrea, Sigouros, Michael, van Besien, Koen, Horwitz, Steven, Rutherford, Sarah C., Mulvey, Erin, Revuelta, Maria V., Xiang, Jenny, Alonso, Alicia, Melnick, Ari, Elemento, Olivier, Inghirami, Giorgio, Leonard, John P., Cerchietti, Leandro, Martin, Peter

Get full text

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study by Qualls, David A, Lambert, Nicholas, Caimi, Paolo F, Merrill, Mwanasha, Pullarkat, Priyanka, Godby, Richard C, Bond, David A, Wehmeyer, Graham T, Romancik, Jason, Amoozgar, Behzad, Leslie, Lori, Nastoupil, Loretta J, Crombie, Jennifer L, Abramson, Jeremy S, Khurana, Arushi, Nowakowski, Grzegorz S, Maddocks, Kami, Rutherford, Sarah C, Kahl, Brad, Okwali, Michelle, Buege, Michael J, Seshan, Venkatraman, Batlevi, Connie L, Salles, Gilles

Get full text

Lymphoma “benchmark” or “bench-smudge”? by Rutherford, Sarah C., Leonard, John P.

Get full text

PET beyond Deauville in diffuse large B-cell lymphoma by Rutherford, Sarah C.

Get full text

Bone marrow biopsies not indicated for response assessment in follicular lymphoma trials regardless of type of imaging study – Response to Adams and Kwee by Rutherford, Sarah C., Leonard, John P.

Get full text

Bone marrow biopsies do not impact response assessment for follicular lymphoma patients treated on clinical trials by Rutherford, Sarah C., Li, Valery, Ghione, Paola, Chen, Zhengming, Martin, Peter, Leonard, John P.

Get full text

Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations by Rutherford, Sarah C., Fachel, Angela A., Li, Sheng, Sawh, Seema, Muley, Ashlesha, Ishii, Jennifer, Saxena, Ashish, Dominguez, Pilar M., Caldas Lopes, Eloisi, Agirre, Xabier, Chambwe, Nyasha, Correa, Fabian, Jiang, Yanwen, Richards, Kristy L., Betel, Doron, Shaknovich, Rita

Get full text

Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomas by Marullo, Rossella, Rutherford, Sarah C., Leonard, John P., Cerchietti, Leandro

Get full text

Unmet mental health needs in patients with advanced B-cell lymphomas by Marte, Chrystal, George, Login S., Rutherford, Sarah C., Ouyang, Daniel Jie, Martin, Peter, Leonard, John P., Trevino, Kelly M.

Get full text

Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation by Loh, Kah Poh, Baran, Andrea, Lee, Christina Y., Alshaibani, Alfadel, Rutherford, Sarah C., Hu, John, Casulo, Carla, Barr, Paul M., Friedberg, Jonathan W., Reagan, Patrick M.

Get full text

Microenvironmental Signatures Reveal Biological Subtypes of Diffuse Large B-Cell Lymphoma (DLBCL) Distinct from Tumor Cell Molecular Profiling by Cerchietti, Leandro, Inghirami, Giorgio, Kotlov, Nikita, Svekolkin, Viktor, Bagaev, Alexander, Frenkel, Felix, Revuelta, Maria Victoria, Phillip, Jude M, Cacciapuoti, Maria Teresa, Rutherford, Sarah C., Martin, Peter, Leonard, John P.

Get full text

Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma by Dickinson, Michael, Briones, Javier, Herrera, Alex F., González-Barca, Eva, Ghosh, Nilanjan, Cordoba, Raul, Rutherford, Sarah C., Bournazou, Eirini, Labriola-Tompkins, Emily, Franjkovic, Izolda, Chesne, Evelyne, Brouwer-Visser, Jurriaan, Lechner, Katharina, Brennan, Barbara, Nüesch, Eveline, DeMario, Mark, Rüttinger, Dominik, Kornacker, Martin, Hutchings, Martin

Get full text

Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma by Orfali, Nina, Jhanwar, Yuliya, Koo, Calvin, Pasciolla, Michelle, Baldo, Maria, Cuvilly, Edwidge, Furman, Richard, Gergis, Usama, Greenberg, June, Guarneri, Danielle, Hsu, Jing-Mei, Leonard, John P., Mark, Tomer, Mayer, Sebastian, Maignan, Kathleen, Martin, Peter, Opong, Adomah, Pearse, Roger, Phillips, Adrienne, Rossi, Adriana, Ruan, Jia, Rutherford, Sarah C., Ryan, Jessy, Suhu, Grace, Van Besien, Koen, Shore, Tsiporah

Get full text

Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience by Hamid, Muhammad Saad, Rutherford, Sarah C., Jang, Hyejeong, Kim, Seongho, Patel, Krish, Bartlett, Nancy L., Malecek, Mary-Kate, Watkins, Marcus P., Maddocks, Kami J., Bond, David A., Feldman, Tatyana A., Magarelli, Gabriela, Advani, Ranjana H, Spinner, Michael A, Evens, Andrew M., Shah, Mansi, Ahmed, Sairah, Stephens, Deborah M., Allen, Pamela, Tees, Michael T., Karmali, Reem, Cheson, Bruce D., Yazdy, Maryam Sarraf, Strouse, Christopher, Bailey, Neil A., Pagel, John M., Ramchandren, Radhakrishnan

Get full text

Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma by Rutherford, Sarah C., Yin, Jun, Pederson, Levi D., Blum, Kristie A., Martin, Peter, Jung, Sin-Ho, Grant, Barbara, Rosenbaum, Cara, Cheson, Bruce D., Bartlett, Nancy L., Mandrekar, Sumithra J., Leonard, John P.

Get full text

The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data by Rutherford, Sarah C., Stewart, Eric N., Chen, Zhengming, Chadburn, Amy, Wehrli, Natasha E., van Besien, Koen, Martin, Peter, Furman, Richard R., Leonard, John P., Cerchietti, Leandro

Get full text

Disease Course and Risk Model Validation of Asymptomatic Waldenström Macroglobulinemia Patients - a Single Center Experience by Akhlaghi, Theresia, Fernandez-Rengifo, Jose, Mejia Saldarriaga, Mateo, Rutherford, Sarah C., Rosenbaum, Cara, Monge, Jorge, Martin, Peter, Allan, John N., Furman, Richard R., Niesvizky, Ruben, Bustoros, Mark

Get full text